LAUREN POLLICINO: Open Payments
NPI 1912987462 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,448 in 99 payments from 17 companies in 2025. Trend: 2023 $2,642 · 2024 $1,968 · 2025 $2,448
Food & beverage: $2,348Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $437 |
| Incyte Corporation | 9 | $281 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $281 |
| GENZYME CORPORATION | 8 | $247 |
| UCB, Inc. | 19 | $242 |
| Amgen Inc. | 11 | $222 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| ABBVIE INC. | 4 | $94 |
| LEO Pharma Inc. | 3 | $85 |
| PFIZER INC. | 4 | $67 |
Products named: TREMFYA, DUPIXENT, OPZELURA, Bimzelx, OTEZLA, ILUMYA, COSENTYX, RINVOQ.
Industry payments across MD — which companies pay providers there.
